DE602005005284D1 - Prion-Assays mit hoher Durchlaufleistung - Google Patents

Prion-Assays mit hoher Durchlaufleistung

Info

Publication number
DE602005005284D1
DE602005005284D1 DE602005005284T DE602005005284T DE602005005284D1 DE 602005005284 D1 DE602005005284 D1 DE 602005005284D1 DE 602005005284 T DE602005005284 T DE 602005005284T DE 602005005284 T DE602005005284 T DE 602005005284T DE 602005005284 D1 DE602005005284 D1 DE 602005005284D1
Authority
DE
Germany
Prior art keywords
sample
prpsc
followed
analysis
specific detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005005284T
Other languages
English (en)
Other versions
DE602005005284T2 (de
Inventor
Walter Eberle
Werner Stock
Baerbel Winter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics GmbH filed Critical Roche Diagnostics GmbH
Publication of DE602005005284D1 publication Critical patent/DE602005005284D1/de
Application granted granted Critical
Publication of DE602005005284T2 publication Critical patent/DE602005005284T2/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
DE602005005284T 2004-11-15 2005-11-14 Prion-Assays mit hoher Durchlaufleistung Active DE602005005284T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04027088 2004-11-15
EP04027088 2004-11-15

Publications (2)

Publication Number Publication Date
DE602005005284D1 true DE602005005284D1 (de) 2008-04-24
DE602005005284T2 DE602005005284T2 (de) 2009-04-16

Family

ID=34927388

Family Applications (2)

Application Number Title Priority Date Filing Date
DE602005005284T Active DE602005005284T2 (de) 2004-11-15 2005-11-14 Prion-Assays mit hoher Durchlaufleistung
DE602005007458T Active DE602005007458D1 (de) 2004-11-15 2005-11-14 Hoch-Durchsatz Prion Tests

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE602005007458T Active DE602005007458D1 (de) 2004-11-15 2005-11-14 Hoch-Durchsatz Prion Tests

Country Status (5)

Country Link
US (1) US7741054B2 (de)
EP (3) EP1677114A1 (de)
AT (2) ATE389182T1 (de)
CA (1) CA2523745C (de)
DE (2) DE602005005284T2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010084201A1 (en) 2009-01-26 2010-07-29 Commissariat A L'energie Atomique Et Aux Energies Alternatives Novel derivative of erythromycin for the treatment and diagnosis of prion disease
CN103344760B (zh) * 2013-07-23 2015-08-26 成都安铂奥金生物科技有限公司 一种高通量免疫组化检测方法及多样品免疫组化检测板
EP2842962A1 (de) * 2013-08-30 2015-03-04 Ludwig-Maximilians-Universität München Verfahren zur Isolierung eines rekombinanten Prionproteins und Verwendung davon

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2208511A (en) * 1987-08-07 1989-04-05 Bayer Ag Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
JP2848840B2 (ja) * 1989-03-03 1999-01-20 国際試薬株式会社 Ｇｏｔアイソザイムの分別定量法
DE19730132C2 (de) * 1997-07-14 2000-01-20 Fraunhofer Ges Forschung Verfahren zum Nachweis von Prionen sowie eine Vorrichtung hierzu
DE10107083C2 (de) * 2001-02-13 2003-02-20 Abdulgabar Salama Pentosan Polysulfat als Ligand zum Nachweis von Prionen
DE10119713A1 (de) * 2001-04-21 2002-10-24 Prionics Ag Zuerich Verfahren zur Untersuchung von Prion-Protein enthaltenden Proben auf das eventuelle Vorliegen der PrPSc-Form
EP1721609A3 (de) 2001-05-16 2007-01-31 GPC Biotech AG Pyridylpyrimidinderivate als effektive Verbindungen gegen Prioninfektionen und prion Erkrankungen
WO2003001211A1 (en) * 2001-06-22 2003-01-03 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Method for testing the presence of prion proteins in tissue and culture samples
AU2002352042A1 (en) * 2002-11-18 2004-06-15 Prionics Ag Method for the detection of prpsc

Also Published As

Publication number Publication date
EP1674870B1 (de) 2008-06-11
EP1677115A2 (de) 2006-07-05
EP1674870A3 (de) 2006-09-20
ATE398288T1 (de) 2008-07-15
EP1677115B1 (de) 2008-03-12
CA2523745A1 (en) 2006-05-15
US7741054B2 (en) 2010-06-22
ATE389182T1 (de) 2008-03-15
US20060121507A1 (en) 2006-06-08
DE602005007458D1 (de) 2008-07-24
DE602005005284T2 (de) 2009-04-16
EP1677114A1 (de) 2006-07-05
EP1674870A2 (de) 2006-06-28
EP1677115A3 (de) 2006-09-20
CA2523745C (en) 2011-08-09

Similar Documents

Publication Publication Date Title
DE60028040D1 (de) Annexin-proteine und auto-antikörper als serummarker für lungenkrebs und ösophaguskrebs
Meldal The one‐bead two‐compound assay for solid phase screening of combinatorial libraries
DE69926248D1 (de) Test zum nachweis von prionen-proteinen die in einer mit krankheit assoziierten konformationen vorliegen
EP1379693A4 (de) Auf oligonukleotid-modifizierten partikeln basierende bio-strichcodes
TW200801515A (en) Alzheimer's disease-specific alterations of the ERK1/ERK2 phosphorylation ratio- alzheimer's disease-specific molecular biomarkers (ADSMB)
AU2006226120B2 (en) Antigen detection
DE60308259D1 (de) Immunologische Verfahren, Vorrichtungen und Reagenzien
CN1864068B (zh) 用小表位抗体降低样品复杂度的方法
CN101506658A (zh) 分泌粒蛋白和vgf肽生物标记及它们的用途
DE602005005284D1 (de) Prion-Assays mit hoher Durchlaufleistung
WO2011037827A3 (en) Identification of discriminant proteins through antibody profiling, methods and apparatus for identifying an individual
CN2735340Y (zh) Sars抗体筛选多肽芯片的制备与检测试剂盒
RU2011140006A (ru) Способ детекции вещества в биологическом образце
ATE462001T1 (de) Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit
CN101087877A (zh) 抗人可溶性血纤蛋白单克隆抗体及使用该抗体的免疫学测定方法
CN117203527A (zh) 鉴定蛋白质或蛋白质组的存在和/或浓度和/或量的方法
DE60311871D1 (de) Verfahren zur detektion von prp unter verwendung ein makrozyklischen ligand
Pavelka et al. The determination of domesticated animal species from a Neolithic sample using the ELISA test
DE602004015932D1 (de) Verfahren zur bildung eines protein-mikroarraysystems
CN106220722B (zh) Dkk1自身抗体识别的抗原多肽及其用途
CN104360074A (zh) 血浆脂蛋白磷脂酶a2的时间分辨荧光免疫检测方法及试剂盒
CN1639572A (zh) 用于抗－ingap抗体的测定
RU2009139650A (ru) Цепь с1 белка 2 промежуточного слоя хряща и его использование для дифференциальной диагностики остеоартрита от ревматоидного артрита и непатологических состояний
JP2004528561A (ja) プリオンタンパク質含有サンプルをＰｒＰＳｃ型の存在可能性について試験する方法
JP2002131232A (ja) ヒドロキシプロリンの検出方法および検出用キット

Legal Events

Date Code Title Description
8364 No opposition during term of opposition